Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Elevation Oncology, Inc. (ELEV)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
25 May 2022
venBio Global Strategic Fund III, L.P.
10% Owner
Elevation Oncology, Inc.
(ELEV)
1,905,430
-26%
702,737
$4.12
$2,897,806.20
BUY
29 Jun 2021
Cormorant Asset Management, LP
Former 10% Owner
Elevation Oncology, Inc.
(ELEV)
2,233,168
+12%
250,000
$16.00
$4,000,000.00
BUY
29 Jun 2021
Qiming U.S. Healthcare Fund II, L.P.
10% Owner
Elevation Oncology, Inc.
(ELEV)
2,370,142
+15%
312,500
$16.00
$5,000,000.00
BUY
29 Jun 2021
Aisling Capital IV, LP
10% Owner
Elevation Oncology, Inc.
(ELEV)
2,834,910
+7%
187,500
$16.00
$3,000,000.00
BUY
29 Jun 2021
venBio Global Strategic Fund III, L.P.
10% Owner
Elevation Oncology, Inc.
(ELEV)
2,608,167
+31%
625,000
$16.00
$10,000,000.00
BUY
29 Jun 2021
Vertex Global HC Fund II Pte. Ltd.
10% Owner
Elevation Oncology, Inc.
(ELEV)
2,307,642
+12%
250,000
$16.00
$4,000,000.00
Home